Assignee
BIOTHERANOSTICS INC
US·15 granted patents·13 pending applications·122 citations·filing 2003–2024
Top patents by PatentIndex Score
28 records- 0194US7504214B2Predicting outcome with tamoxifen in breast cancerBIOTHERANOSTICS INC·Filed 2003·Granted Mar 17, 2009·105 cites·43 claims
- 0293US7930105B2Grading of breast cancerBIOTHERANOSTICS INC·Filed 2007·Granted Apr 19, 2011·10 cites·20 claims
- 0388US10329624B2Grading of breast cancerBIOTHERANOSTICS INC·Filed 2016·Granted Jun 25, 2019·2 cites·16 claims
- 0488US9670553B2Determining tumor originBIOTHERANOSTICS INC·Filed 2015·Granted Jun 6, 2017·3 cites·15 claims
- 0581US11430544B2Identification of tumors and tissuesBIOTHERANOSTICS INC·Filed 2016·Granted Aug 30, 2022·1 cites·8 claims
- 0681US2025215506A1Integration of tumor characteristics with breast cancer indexBIOTHERANOSTICS INC·Filed 2024·Application pending·0 cites
- 0780US10538816B2Identification of tumorsBIOTHERANOSTICS INC·Filed 2016·Granted Jan 21, 2020·1 cites·20 claims
- 0879US2023023867A1Identification of tumors and tissuesBIOTHERANOSTICS INC·Filed 2022·Application pending·0 cites
- 0978US12595516B2Neuroendocrine tumorsBIOTHERANOSTICS INC·Filed 2022·Granted Apr 7, 2026·0 cites·8 claims
- 1076US12215390B2Integration of tumor characteristics with breast cancer indexBIOTHERANOSTICS INC·Filed 2022·Granted Feb 4, 2025·0 cites·20 claims
- 1175US2020190597A1Identification of tumorsBIOTHERANOSTICS INC·Filed 2019·Application pending·0 cites
- 1274US2020095642A1Grading of breast cancerBIOTHERANOSTICS INC·Filed 2019·Application pending·0 cites
- 1373US12492432B2Tumor grading and cancer prognosisBIOTHERANOSTICS INC·Filed 2021·Granted Dec 9, 2025·0 cites·19 claims
- 1472US12460265B2Post-treatment breast cancer prognosisBIOTHERANOSTICS INC·Filed 2021·Granted Nov 4, 2025·0 cites·11 claims
- 1568US2010047787A1Prostate cancer survival and recurrenceBIOTHERANOSTICS INC·Filed 2009·Application pending·0 cites
- 1667US11021754B2Tumor grading and cancer prognosisBIOTHERANOSTICS INC·Filed 2017·Granted Jun 1, 2021·0 cites·16 claims
- 1767US2013023441A1Identification of TumorsBIOTHERANOSTICS INC·Filed 2012·Application pending·0 cites
- 1866US2014349856A1Neuroendocrine TumorsBIOTHERANOSTICS INC·Filed 2014·Application pending·0 cites
- 1965US11549148B2Neuroendocrine tumorsBIOTHERANOSTICS INC·Filed 2017·Granted Jan 10, 2023·0 cites·10 claims
- 2065US2022186317A1Predicting breast cancer recurrenceBIOTHERANOSTICS INC·Filed 2021·Application pending·0 cites
- 2162US2018073085A1Determining tumor originBIOTHERANOSTICS INC·Filed 2017·Application pending·0 cites
- 2261US11530448B2Integration of tumor characteristics with breast cancer indexBIOTHERANOSTICS INC·Filed 2016·Granted Dec 20, 2022·0 cites·19 claims
- 2361US11078538B2Post-treatment breast cancer prognosisBIOTHERANOSTICS INC·Filed 2016·Granted Aug 3, 2021·0 cites·15 claims
- 2460US2022106646A1Determining tumor originBIOTHERANOSTICS INC·Filed 2021·Application pending·0 cites
- 2558US2018127834A1Predicting breast cancer treatment outcomeBIOTHERANOSTICS INC·Filed 2017·Application pending·0 cites
- 2657US2018051342A1Prostate cancer survival and recurrenceBIOTHERANOSTICS INC·Filed 2017·Application pending·0 cites
- 2751US2015203921A1Predicting breast cancer recurrenceBIOTHERANOSTICS INC·Filed 2014·Application pending·0 cites
- 2842US10253369B2Predicting likelihood of response to combination therapyBIOTHERANOSTICS INC·Filed 2015·Granted Apr 9, 2019·0 cites·18 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →